![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1307.jpg)
Alternated day treatment is better: Sequentially 16% developed CBOS, whereas only
12% patients who received treatment every alternate day (group II) developed CBOS.
Only 14% patients with CBOS survived in group I, whereas 50% in group II who
developed CBOS survived.